No Data
Why Zhejiang Hisun BiomaterialsLtd's (SHSE:688203) Shaky Earnings Are Just The Beginning Of Its Problems
Haizheng Raw Materials: Zhejiang Haizheng Biomaterials Co., Ltd. Report for the Third Quarter of 2024
Zhejiang Haizheng Biomaterials Co., Ltd. Report for the Third Quarter of 2024
Hisun Biomaterials Repurchases Shares Under 30 Million Yuan Buyback Scheme
Haizheng Life Sciences (688203.SH): Director Shen Xinghu resigns.
On August 28th, Hai Zheng Sheng Cai (688203.SH) announced that on August 28th, 2024, the board of directors received a written resignation report from Mr. Shen Xinghu, the Chairman of the Company. Due to personal reasons, Mr. Shen Xinghu requested to resign from the seventh board of directors, Chairman of the board of directors, member of the board of directors' audit committee, and convener of the board of directors' strategic committee, and no longer serve as the Company's legal representative. After resigning, Mr. Shen Xinghu will not hold any position in the Company.
Haizheng Shengcai (688203.SH) plans to spend 20 to 30 million yuan to repurchase shares.
Haizheng Biomaterials (688203.SH) announced that the company plans to repurchase some of the shares through centralized auction trading with its own funds...
Zhejiang Hisun BiomaterialsLtd (SHSE:688203) May Have Issues Allocating Its CapitalNo Data
No Data
